Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Recurrent Pregnancy Loss
2024-515579-36-00Phase 2Authorised
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in recurrent miscarriage (RPL) comparing Hydroxychloroquine (Plaquenil) with Placebo (2 arms). Primary endpoint: Completion of follow-up for 186 women. Planned start Jul 2024; status: authorised.
02
Drugs
hydroxychloroquine
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on 2024-515579-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515579-36-00.